Report Overview
Equine Pharmaceuticals and Supplements are medicines or supplements that are specially used to supplement nutrition and cure diseases.
The global Equine Pharmaceuticals and Supplements market size was estimated at USD 1148 million in 2023 and is projected to reach USD 1706.04 million by 2032, exhibiting a CAGR of 4.50% during the forecast period.
North America Equine Pharmaceuticals and Supplements market size was estimated at USD 322.66 million in 2023, at a CAGR of 3.86% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Equine Pharmaceuticals and Supplements market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Equine Pharmaceuticals and Supplements Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Equine Pharmaceuticals and Supplements market in any manner.
Global Equine Pharmaceuticals and Supplements Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Boehringer Ingelheim
Merck Animal Health
Zoetis
Bayer Animal Health
Elanco Animal Health
Dechra Veterinary Products
CEVA
Virbac
Norbrook Equine
Kyoritsu Seiyaku
Vetoquinol
Protexin Healthcare
Audevard
Ouro Fino Saude
Market Segmentation (by Type)
Pharmaceuticals
Supplements
Market Segmentation (by Application)
Thoroughbred Horse
Other Types of Horses
Geographic Segmentation
� North America (USA, Canada, Mexico)
� Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
� Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
� South America (Brazil, Argentina, Columbia, Rest of South America)
� The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
� Industry drivers, restraints, and opportunities covered in the study
� Neutral perspective on the market performance
� Recent industry trends and developments
� Competitive landscape & strategies of key players
� Potential & niche segments and regions exhibiting promising growth covered
� Historical, current, and projected market size, in terms of value
� In-depth analysis of the Equine Pharmaceuticals and Supplements Market
� Overview of the regional outlook of the Equine Pharmaceuticals and Supplements Market:
Key Reasons to Buy this Report:
� Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
� This enables you to anticipate market changes to remain ahead of your competitors
� You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
� The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
� Provision of market value data for each segment and sub-segment
� Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
� Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
� Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
� Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
� The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
� Includes in-depth analysis of the market from various perspectives through Porter�s five forces analysis
� Provides insight into the market through Value Chain
� Market dynamics scenario, along with growth opportunities of the market in the years to come
� 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Equine Pharmaceuticals and Supplements Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Equine Pharmaceuticals and Supplements, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Equine Pharmaceuticals and Supplements
1.2 Key Market Segments
1.2.1 Equine Pharmaceuticals and Supplements Segment by Type
1.2.2 Equine Pharmaceuticals and Supplements Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Equine Pharmaceuticals and Supplements Market Overview
2.1 Global Market Overview
2.1.1 Global Equine Pharmaceuticals and Supplements Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Equine Pharmaceuticals and Supplements Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Equine Pharmaceuticals and Supplements Market Competitive Landscape
3.1 Global Equine Pharmaceuticals and Supplements Sales by Manufacturers (2019-2025)
3.2 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Manufacturers (2019-2025)
3.3 Equine Pharmaceuticals and Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Equine Pharmaceuticals and Supplements Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Equine Pharmaceuticals and Supplements Sales Sites, Area Served, Product Type
3.6 Equine Pharmaceuticals and Supplements Market Competitive Situation and Trends
3.6.1 Equine Pharmaceuticals and Supplements Market Concentration Rate
3.6.2 Global 5 and 10 Largest Equine Pharmaceuticals and Supplements Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Equine Pharmaceuticals and Supplements Industry Chain Analysis
4.1 Equine Pharmaceuticals and Supplements Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Equine Pharmaceuticals and Supplements Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Equine Pharmaceuticals and Supplements Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2019-2025)
6.3 Global Equine Pharmaceuticals and Supplements Market Size Market Share by Type (2019-2025)
6.4 Global Equine Pharmaceuticals and Supplements Price by Type (2019-2025)
7 Equine Pharmaceuticals and Supplements Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Equine Pharmaceuticals and Supplements Market Sales by Application (2019-2025)
7.3 Global Equine Pharmaceuticals and Supplements Market Size (M USD) by Application (2019-2025)
7.4 Global Equine Pharmaceuticals and Supplements Sales Growth Rate by Application (2019-2025)
8 Equine Pharmaceuticals and Supplements Market Consumption by Region
8.1 Global Equine Pharmaceuticals and Supplements Sales by Region
8.1.1 Global Equine Pharmaceuticals and Supplements Sales by Region
8.1.2 Global Equine Pharmaceuticals and Supplements Sales Market Share by Region
8.2 North America
8.2.1 North America Equine Pharmaceuticals and Supplements Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Equine Pharmaceuticals and Supplements Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Equine Pharmaceuticals and Supplements Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Equine Pharmaceuticals and Supplements Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Equine Pharmaceuticals and Supplements Market Production by Region
9.1 Global Production of Equine Pharmaceuticals and Supplements by Region (2019-2025)
9.2 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Region (2019-2025)
9.3 Global Equine Pharmaceuticals and Supplements Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Equine Pharmaceuticals and Supplements Production
9.4.1 North America Equine Pharmaceuticals and Supplements Production Growth Rate (2019-2025)
9.4.2 North America Equine Pharmaceuticals and Supplements Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Equine Pharmaceuticals and Supplements Production
9.5.1 Europe Equine Pharmaceuticals and Supplements Production Growth Rate (2019-2025)
9.5.2 Europe Equine Pharmaceuticals and Supplements Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Equine Pharmaceuticals and Supplements Production (2019-2025)
9.6.1 Japan Equine Pharmaceuticals and Supplements Production Growth Rate (2019-2025)
9.6.2 Japan Equine Pharmaceuticals and Supplements Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Equine Pharmaceuticals and Supplements Production (2019-2025)
9.7.1 China Equine Pharmaceuticals and Supplements Production Growth Rate (2019-2025)
9.7.2 China Equine Pharmaceuticals and Supplements Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Boehringer Ingelheim
10.1.1 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Basic Information
10.1.2 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Overview
10.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Market Performance
10.1.4 Boehringer Ingelheim Business Overview
10.1.5 Boehringer Ingelheim Equine Pharmaceuticals and Supplements SWOT Analysis
10.1.6 Boehringer Ingelheim Recent Developments
10.2 Merck Animal Health
10.2.1 Merck Animal Health Equine Pharmaceuticals and Supplements Basic Information
10.2.2 Merck Animal Health Equine Pharmaceuticals and Supplements Product Overview
10.2.3 Merck Animal Health Equine Pharmaceuticals and Supplements Product Market Performance
10.2.4 Merck Animal Health Business Overview
10.2.5 Merck Animal Health Equine Pharmaceuticals and Supplements SWOT Analysis
10.2.6 Merck Animal Health Recent Developments
10.3 Zoetis
10.3.1 Zoetis Equine Pharmaceuticals and Supplements Basic Information
10.3.2 Zoetis Equine Pharmaceuticals and Supplements Product Overview
10.3.3 Zoetis Equine Pharmaceuticals and Supplements Product Market Performance
10.3.4 Zoetis Equine Pharmaceuticals and Supplements SWOT Analysis
10.3.5 Zoetis Business Overview
10.3.6 Zoetis Recent Developments
10.4 Bayer Animal Health
10.4.1 Bayer Animal Health Equine Pharmaceuticals and Supplements Basic Information
10.4.2 Bayer Animal Health Equine Pharmaceuticals and Supplements Product Overview
10.4.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Product Market Performance
10.4.4 Bayer Animal Health Business Overview
10.4.5 Bayer Animal Health Recent Developments
10.5 Elanco Animal Health
10.5.1 Elanco Animal Health Equine Pharmaceuticals and Supplements Basic Information
10.5.2 Elanco Animal Health Equine Pharmaceuticals and Supplements Product Overview
10.5.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Product Market Performance
10.5.4 Elanco Animal Health Business Overview
10.5.5 Elanco Animal Health Recent Developments
10.6 Dechra Veterinary Products
10.6.1 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Basic Information
10.6.2 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Overview
10.6.3 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Market Performance
10.6.4 Dechra Veterinary Products Business Overview
10.6.5 Dechra Veterinary Products Recent Developments
10.7 CEVA
10.7.1 CEVA Equine Pharmaceuticals and Supplements Basic Information
10.7.2 CEVA Equine Pharmaceuticals and Supplements Product Overview
10.7.3 CEVA Equine Pharmaceuticals and Supplements Product Market Performance
10.7.4 CEVA Business Overview
10.7.5 CEVA Recent Developments
10.8 Virbac
10.8.1 Virbac Equine Pharmaceuticals and Supplements Basic Information
10.8.2 Virbac Equine Pharmaceuticals and Supplements Product Overview
10.8.3 Virbac Equine Pharmaceuticals and Supplements Product Market Performance
10.8.4 Virbac Business Overview
10.8.5 Virbac Recent Developments
10.9 Norbrook Equine
10.9.1 Norbrook Equine Equine Pharmaceuticals and Supplements Basic Information
10.9.2 Norbrook Equine Equine Pharmaceuticals and Supplements Product Overview
10.9.3 Norbrook Equine Equine Pharmaceuticals and Supplements Product Market Performance
10.9.4 Norbrook Equine Business Overview
10.9.5 Norbrook Equine Recent Developments
10.10 Kyoritsu Seiyaku
10.10.1 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Basic Information
10.10.2 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Overview
10.10.3 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Market Performance
10.10.4 Kyoritsu Seiyaku Business Overview
10.10.5 Kyoritsu Seiyaku Recent Developments
10.11 Vetoquinol
10.11.1 Vetoquinol Equine Pharmaceuticals and Supplements Basic Information
10.11.2 Vetoquinol Equine Pharmaceuticals and Supplements Product Overview
10.11.3 Vetoquinol Equine Pharmaceuticals and Supplements Product Market Performance
10.11.4 Vetoquinol Business Overview
10.11.5 Vetoquinol Recent Developments
10.12 Protexin Healthcare
10.12.1 Protexin Healthcare Equine Pharmaceuticals and Supplements Basic Information
10.12.2 Protexin Healthcare Equine Pharmaceuticals and Supplements Product Overview
10.12.3 Protexin Healthcare Equine Pharmaceuticals and Supplements Product Market Performance
10.12.4 Protexin Healthcare Business Overview
10.12.5 Protexin Healthcare Recent Developments
10.13 Audevard
10.13.1 Audevard Equine Pharmaceuticals and Supplements Basic Information
10.13.2 Audevard Equine Pharmaceuticals and Supplements Product Overview
10.13.3 Audevard Equine Pharmaceuticals and Supplements Product Market Performance
10.13.4 Audevard Business Overview
10.13.5 Audevard Recent Developments
10.14 Ouro Fino Saude
10.14.1 Ouro Fino Saude Equine Pharmaceuticals and Supplements Basic Information
10.14.2 Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Overview
10.14.3 Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Market Performance
10.14.4 Ouro Fino Saude Business Overview
10.14.5 Ouro Fino Saude Recent Developments
11 Equine Pharmaceuticals and Supplements Market Forecast by Region
11.1 Global Equine Pharmaceuticals and Supplements Market Size Forecast
11.2 Global Equine Pharmaceuticals and Supplements Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Equine Pharmaceuticals and Supplements Market Size Forecast by Country
11.2.3 Asia Pacific Equine Pharmaceuticals and Supplements Market Size Forecast by Region
11.2.4 South America Equine Pharmaceuticals and Supplements Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Equine Pharmaceuticals and Supplements by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Equine Pharmaceuticals and Supplements Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Equine Pharmaceuticals and Supplements by Type (2025-2032)
12.1.2 Global Equine Pharmaceuticals and Supplements Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Equine Pharmaceuticals and Supplements by Type (2025-2032)
12.2 Global Equine Pharmaceuticals and Supplements Market Forecast by Application (2025-2032)
12.2.1 Global Equine Pharmaceuticals and Supplements Sales (K MT) Forecast by Application
12.2.2 Global Equine Pharmaceuticals and Supplements Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Equine Pharmaceuticals and Supplements Market Size Comparison by Region (M USD)
Table 5. Global Equine Pharmaceuticals and Supplements Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Equine Pharmaceuticals and Supplements Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Equine Pharmaceuticals and Supplements Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Equine Pharmaceuticals and Supplements Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Equine Pharmaceuticals and Supplements as of 2022)
Table 10. Global Market Equine Pharmaceuticals and Supplements Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Equine Pharmaceuticals and Supplements Sales Sites and Area Served
Table 12. Manufacturers Equine Pharmaceuticals and Supplements Product Type
Table 13. Global Equine Pharmaceuticals and Supplements Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Equine Pharmaceuticals and Supplements
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Equine Pharmaceuticals and Supplements Market Challenges
Table 22. Global Equine Pharmaceuticals and Supplements Sales by Type (K MT)
Table 23. Global Equine Pharmaceuticals and Supplements Market Size by Type (M USD)
Table 24. Global Equine Pharmaceuticals and Supplements Sales (K MT) by Type (2019-2025)
Table 25. Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2019-2025)
Table 26. Global Equine Pharmaceuticals and Supplements Market Size (M USD) by Type (2019-2025)
Table 27. Global Equine Pharmaceuticals and Supplements Market Size Share by Type (2019-2025)
Table 28. Global Equine Pharmaceuticals and Supplements Price (USD/MT) by Type (2019-2025)
Table 29. Global Equine Pharmaceuticals and Supplements Sales (K MT) by Application
Table 30. Global Equine Pharmaceuticals and Supplements Market Size by Application
Table 31. Global Equine Pharmaceuticals and Supplements Sales by Application (2019-2025) & (K MT)
Table 32. Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2019-2025)
Table 33. Global Equine Pharmaceuticals and Supplements Sales by Application (2019-2025) & (M USD)
Table 34. Global Equine Pharmaceuticals and Supplements Market Share by Application (2019-2025)
Table 35. Global Equine Pharmaceuticals and Supplements Sales Growth Rate by Application (2019-2025)
Table 36. Global Equine Pharmaceuticals and Supplements Sales by Region (2019-2025) & (K MT)
Table 37. Global Equine Pharmaceuticals and Supplements Sales Market Share by Region (2019-2025)
Table 38. North America Equine Pharmaceuticals and Supplements Sales by Country (2019-2025) & (K MT)
Table 39. Europe Equine Pharmaceuticals and Supplements Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Equine Pharmaceuticals and Supplements Sales by Region (2019-2025) & (K MT)
Table 41. South America Equine Pharmaceuticals and Supplements Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Region (2019-2025) & (K MT)
Table 43. Global Equine Pharmaceuticals and Supplements Production (K MT) by Region (2019-2025)
Table 44. Global Equine Pharmaceuticals and Supplements Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Region (2019-2025)
Table 46. Global Equine Pharmaceuticals and Supplements Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Equine Pharmaceuticals and Supplements Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Equine Pharmaceuticals and Supplements Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Equine Pharmaceuticals and Supplements Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Equine Pharmaceuticals and Supplements Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Basic Information
Table 52. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Overview
Table 53. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Boehringer Ingelheim Business Overview
Table 55. Boehringer Ingelheim Equine Pharmaceuticals and Supplements SWOT Analysis
Table 56. Boehringer Ingelheim Recent Developments
Table 57. Merck Animal Health Equine Pharmaceuticals and Supplements Basic Information
Table 58. Merck Animal Health Equine Pharmaceuticals and Supplements Product Overview
Table 59. Merck Animal Health Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. Merck Animal Health Business Overview
Table 61. Merck Animal Health Equine Pharmaceuticals and Supplements SWOT Analysis
Table 62. Merck Animal Health Recent Developments
Table 63. Zoetis Equine Pharmaceuticals and Supplements Basic Information
Table 64. Zoetis Equine Pharmaceuticals and Supplements Product Overview
Table 65. Zoetis Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. Zoetis Equine Pharmaceuticals and Supplements SWOT Analysis
Table 67. Zoetis Business Overview
Table 68. Zoetis Recent Developments
Table 69. Bayer Animal Health Equine Pharmaceuticals and Supplements Basic Information
Table 70. Bayer Animal Health Equine Pharmaceuticals and Supplements Product Overview
Table 71. Bayer Animal Health Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. Bayer Animal Health Business Overview
Table 73. Bayer Animal Health Recent Developments
Table 74. Elanco Animal Health Equine Pharmaceuticals and Supplements Basic Information
Table 75. Elanco Animal Health Equine Pharmaceuticals and Supplements Product Overview
Table 76. Elanco Animal Health Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. Elanco Animal Health Business Overview
Table 78. Elanco Animal Health Recent Developments
Table 79. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Basic Information
Table 80. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Overview
Table 81. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Dechra Veterinary Products Business Overview
Table 83. Dechra Veterinary Products Recent Developments
Table 84. CEVA Equine Pharmaceuticals and Supplements Basic Information
Table 85. CEVA Equine Pharmaceuticals and Supplements Product Overview
Table 86. CEVA Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. CEVA Business Overview
Table 88. CEVA Recent Developments
Table 89. Virbac Equine Pharmaceuticals and Supplements Basic Information
Table 90. Virbac Equine Pharmaceuticals and Supplements Product Overview
Table 91. Virbac Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. Virbac Business Overview
Table 93. Virbac Recent Developments
Table 94. Norbrook Equine Equine Pharmaceuticals and Supplements Basic Information
Table 95. Norbrook Equine Equine Pharmaceuticals and Supplements Product Overview
Table 96. Norbrook Equine Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 97. Norbrook Equine Business Overview
Table 98. Norbrook Equine Recent Developments
Table 99. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Basic Information
Table 100. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Overview
Table 101. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 102. Kyoritsu Seiyaku Business Overview
Table 103. Kyoritsu Seiyaku Recent Developments
Table 104. Vetoquinol Equine Pharmaceuticals and Supplements Basic Information
Table 105. Vetoquinol Equine Pharmaceuticals and Supplements Product Overview
Table 106. Vetoquinol Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 107. Vetoquinol Business Overview
Table 108. Vetoquinol Recent Developments
Table 109. Protexin Healthcare Equine Pharmaceuticals and Supplements Basic Information
Table 110. Protexin Healthcare Equine Pharmaceuticals and Supplements Product Overview
Table 111. Protexin Healthcare Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 112. Protexin Healthcare Business Overview
Table 113. Protexin Healthcare Recent Developments
Table 114. Audevard Equine Pharmaceuticals and Supplements Basic Information
Table 115. Audevard Equine Pharmaceuticals and Supplements Product Overview
Table 116. Audevard Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 117. Audevard Business Overview
Table 118. Audevard Recent Developments
Table 119. Ouro Fino Saude Equine Pharmaceuticals and Supplements Basic Information
Table 120. Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Overview
Table 121. Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 122. Ouro Fino Saude Business Overview
Table 123. Ouro Fino Saude Recent Developments
Table 124. Global Equine Pharmaceuticals and Supplements Sales Forecast by Region (2025-2032) & (K MT)
Table 125. Global Equine Pharmaceuticals and Supplements Market Size Forecast by Region (2025-2032) & (M USD)
Table 126. North America Equine Pharmaceuticals and Supplements Sales Forecast by Country (2025-2032) & (K MT)
Table 127. North America Equine Pharmaceuticals and Supplements Market Size Forecast by Country (2025-2032) & (M USD)
Table 128. Europe Equine Pharmaceuticals and Supplements Sales Forecast by Country (2025-2032) & (K MT)
Table 129. Europe Equine Pharmaceuticals and Supplements Market Size Forecast by Country (2025-2032) & (M USD)
Table 130. Asia Pacific Equine Pharmaceuticals and Supplements Sales Forecast by Region (2025-2032) & (K MT)
Table 131. Asia Pacific Equine Pharmaceuticals and Supplements Market Size Forecast by Region (2025-2032) & (M USD)
Table 132. South America Equine Pharmaceuticals and Supplements Sales Forecast by Country (2025-2032) & (K MT)
Table 133. South America Equine Pharmaceuticals and Supplements Market Size Forecast by Country (2025-2032) & (M USD)
Table 134. Middle East and Africa Equine Pharmaceuticals and Supplements Consumption Forecast by Country (2025-2032) & (Units)
Table 135. Middle East and Africa Equine Pharmaceuticals and Supplements Market Size Forecast by Country (2025-2032) & (M USD)
Table 136. Global Equine Pharmaceuticals and Supplements Sales Forecast by Type (2025-2032) & (K MT)
Table 137. Global Equine Pharmaceuticals and Supplements Market Size Forecast by Type (2025-2032) & (M USD)
Table 138. Global Equine Pharmaceuticals and Supplements Price Forecast by Type (2025-2032) & (USD/MT)
Table 139. Global Equine Pharmaceuticals and Supplements Sales (K MT) Forecast by Application (2025-2032)
Table 140. Global Equine Pharmaceuticals and Supplements Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Equine Pharmaceuticals and Supplements
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Equine Pharmaceuticals and Supplements Market Size (M USD), 2019-2032
Figure 5. Global Equine Pharmaceuticals and Supplements Market Size (M USD) (2019-2032)
Figure 6. Global Equine Pharmaceuticals and Supplements Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Equine Pharmaceuticals and Supplements Market Size by Country (M USD)
Figure 11. Equine Pharmaceuticals and Supplements Sales Share by Manufacturers in 2023
Figure 12. Global Equine Pharmaceuticals and Supplements Revenue Share by Manufacturers in 2023
Figure 13. Equine Pharmaceuticals and Supplements Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Equine Pharmaceuticals and Supplements Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Equine Pharmaceuticals and Supplements Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Equine Pharmaceuticals and Supplements Market Share by Type
Figure 18. Sales Market Share of Equine Pharmaceuticals and Supplements by Type (2019-2025)
Figure 19. Sales Market Share of Equine Pharmaceuticals and Supplements by Type in 2023
Figure 20. Market Size Share of Equine Pharmaceuticals and Supplements by Type (2019-2025)
Figure 21. Market Size Market Share of Equine Pharmaceuticals and Supplements by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Equine Pharmaceuticals and Supplements Market Share by Application
Figure 24. Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2019-2025)
Figure 25. Global Equine Pharmaceuticals and Supplements Sales Market Share by Application in 2023
Figure 26. Global Equine Pharmaceuticals and Supplements Market Share by Application (2019-2025)
Figure 27. Global Equine Pharmaceuticals and Supplements Market Share by Application in 2023
Figure 28. Global Equine Pharmaceuticals and Supplements Sales Growth Rate by Application (2019-2025)
Figure 29. Global Equine Pharmaceuticals and Supplements Sales Market Share by Region (2019-2025)
Figure 30. North America Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Equine Pharmaceuticals and Supplements Sales Market Share by Country in 2023
Figure 32. U.S. Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Equine Pharmaceuticals and Supplements Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Equine Pharmaceuticals and Supplements Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Country in 2023
Figure 37. Germany Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Equine Pharmaceuticals and Supplements Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Equine Pharmaceuticals and Supplements Sales Market Share by Region in 2023
Figure 44. China Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Equine Pharmaceuticals and Supplements Sales and Growth Rate (K MT)
Figure 50. South America Equine Pharmaceuticals and Supplements Sales Market Share by Country in 2023
Figure 51. Brazil Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Equine Pharmaceuticals and Supplements Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Equine Pharmaceuticals and Supplements Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Equine Pharmaceuticals and Supplements Production Market Share by Region (2019-2025)
Figure 62. North America Equine Pharmaceuticals and Supplements Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Equine Pharmaceuticals and Supplements Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Equine Pharmaceuticals and Supplements Production (K MT) Growth Rate (2019-2025)
Figure 65. China Equine Pharmaceuticals and Supplements Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Equine Pharmaceuticals and Supplements Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Equine Pharmaceuticals and Supplements Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Equine Pharmaceuticals and Supplements Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Equine Pharmaceuticals and Supplements Market Share Forecast by Type (2025-2032)
Figure 70. Global Equine Pharmaceuticals and Supplements Sales Forecast by Application (2025-2032)
Figure 71. Global Equine Pharmaceuticals and Supplements Market Share Forecast by Application (2025-2032)
